4//SEC Filing
Nivalis Therapeutics, Inc. 4
Accession 0001104659-16-144632
CIK 0001626199operating
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 4:16 PM ET
Size
5.7 KB
Accession
0001104659-16-144632
Insider Transaction Report
Form 4
Furst Howard P.
Director
Transactions
- Award
Stock Option (Right to Buy)
2016-09-12+12,300→ 12,300 totalExercise: $7.77Exp: 2026-09-12→ Common Stock (12,300 underlying)
Footnotes (3)
- [F1]The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
- [F2]The shares shall vest in 12 equal monthly installments commencing on October 12, 2016.
- [F3]The Reporting Person, a partner in Deerfield Management Company, L.P., has no pecuniary interest in the securities reported herein and disclaims beneficial ownership of such securities.
Documents
Issuer
Nivalis Therapeutics, Inc.
CIK 0001626199
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001626199
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 4:16 PM ET
- Size
- 5.7 KB